Dynasty Wealth Management LLC Purchases 515 Shares of McKesson Co. (NYSE:MCK)

Dynasty Wealth Management LLC boosted its holdings in shares of McKesson Co. (NYSE:MCK) by 21.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,958 shares of the company’s stock after buying an additional 515 shares during the period. Dynasty Wealth Management LLC’s holdings in McKesson were worth $1,686,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Synergy Asset Management LLC bought a new position in shares of McKesson during the fourth quarter valued at about $32,000. MidAtlantic Capital Management Inc. bought a new position in shares of McKesson during the 3rd quarter worth approximately $29,000. Crews Bank & Trust bought a new position in shares of McKesson during the 4th quarter worth approximately $33,000. RPg Family Wealth Advisory LLC bought a new position in shares of McKesson during the 3rd quarter worth approximately $31,000. Finally, Creative Capital Management Investments LLC purchased a new position in shares of McKesson in the 4th quarter worth approximately $44,000. 85.07% of the stock is owned by institutional investors.

Insider Activity at McKesson

In related news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the transaction, the chief executive officer now directly owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. This represents a 12.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of McKesson stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now directly owns 1,051 shares of the company’s stock, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 19,268 shares of company stock valued at $11,536,378. 0.11% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Evercore ISI boosted their price objective on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research report on Thursday, February 6th. Bank of America cut their price target on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Citigroup lowered their price objective on shares of McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Mizuho began coverage on shares of McKesson in a research report on Wednesday, December 4th. They set a “neutral” rating and a $630.00 target price for the company. Finally, Baird R W raised shares of McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $645.79.

McKesson Price Performance

NYSE:MCK opened at $621.03 on Friday. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $637.51. The firm’s 50-day moving average price is $592.91 and its 200-day moving average price is $563.46. The company has a market capitalization of $77.83 billion, a PE ratio of 28.44, a P/E/G ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Equities analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s payout ratio is 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.